Research programme: HBV cccDNA inhibitors - ViriomAlternative Names: VM-1010
Latest Information Update: 20 Jul 2016
At a glance
- Originator Viriom
- Class Antivirals; Small molecules
- Mechanism of Action Hepatitis B virus replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatitis B
Most Recent Events
- 20 Jul 2016 Early research is ongoing in Russia
- 04 Mar 2014 Early research in Hepatitis B in Russia (unspecified route)